Diabetes in pregnancy: Health risks and management

Postgraduate Medical Journal

Volumn 87, Issue 1028, 2011, Pages 417-427

  Ali, Sarah ^a   Dornhorst, Anne ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; FOLIC ACID; GLIBENCLAMIDE; HEMOGLOBIN A1C; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ISOPHANE INSULIN; LABETALOL; METFORMIN; METHYLDOPA; NIFEDIPINE;

BLOOD GLUCOSE MONITORING; CONGENITAL MALFORMATION; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG CHOICE; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HUMAN; HYPOGLYCEMIA; KIDNEY FUNCTION; LOW LEVEL LASER THERAPY; MACROSOMIA; MATERNAL CARE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTNATAL CARE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SPONTANEOUS ABORTION; TREATMENT CONTRAINDICATION;

BLOOD GLUCOSE; COUNSELING; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; PERINATAL CARE; POSTNATAL CARE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE;

EID: 79958185772     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2010.109157     Document Type: Review

References (138)

1. Diabetes Care and Research in Europe. The Saint Vincent declaration. Diabet Med 1990;7:360.
2. Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 2008;31:1060e79.
3. Guideline Development Group. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 2008;336:714e17.
4. Dornhorst A, Banerjee A. Diabetes in pregnancy. In: Holt RG, Cockram CS, Flyvbjerg A, et al, eds. Textbook of Diabetes. A Clinical Approach. 4th edn. 2010:888e921.
5. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(Suppl 2):S251e60.
6. Confidential Enquiry into Maternal and Child Health. Pregnancy in women with type 1 and type 2 diabetes in 2002e03, England, Wales, Northern Ireland. London: CEMACH, 2005.
7. Steel JM, Johnstone FD, Hepburn DA, et al. Can prepregnancy care of women with diabetes reduce the risk of abnormal babies? BMJ 1990;301:1070e4.
8. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 2001;94:435e44.
9. Pearson DW, Kernaghan D, Lee R, et al. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus. BJOG 2007;114:104e7.
10. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328:915.
11. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006;29:1744e9.
12. Holing EV, Beyer CS, Brown ZA, et al. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998;21:889e95.
13. Greene MF, Hare JW, Cloherty JP, et al. First trimester hemoglobin A1C and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989;39:225e31.
14. Temple R, Aldridge V, Greenwood R, et al. Association between outcome of pregnancy and glycemic control in early pregnancy in type 1 diabetes: population based study. BMJ 2002;325:1275e6.
15. Fuhrmann K, Reiher H, Semmler K, et al. Prevention of congenital malformations of infants of insulin-dependent mother with diabetes. Diabetes Care 1983;6:219e23.
16. Hawthorne G, Robson S, Ryall EA, et al. Prospective population based survey of outcome of pregnancy in women with diabetes: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 1997;315:279e81.
17. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent women with diabetes: results of a five year population cohort study. BMJ 1997;315:275e8.
18. Goldman JA, Dicker D, Feldberg D, et al. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am J Obstet Gynecol 1986;155:293e7.
19. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception management of diabetes continued through early pregnancy prevents the excess frequency of major congenital anomalies in infants of mother with diabetes. JAMA 1991;265:731e6.
20. Bell R, Bailey K, Cresswell T, et al. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 2008;115:445e52.
21. Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009;32:1046e8.
22. Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007;30:1920e5.
23. Holing EV. Preconception care of women with diabetes: the unrevealed obstacles. J Matern Fetal Med 2000;9:10e13.
24. Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 2006;333:177.
25. Lauenborg J, Mathiesen E, Ovesen P, et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 2003;26:1385e9.
26. Karlsson K, Kjellmer I. The outcome of diabetic pregnancies in relationship to the mother's blood sugar level. Am J Obstet Gynecol 1972;112:213e20.
27. Mills JL, Baker L, Goldman AS. Malformations in infants of mother with diabetes occur before the seventh gestational week. Implications for treatment. Diabetes 1979;28:292e3.
28. Martinez-Frias ML. Epidemiological analysis of outcomes of pregnancy in mother with diabetes: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 1994;51:108e13.
29. Mills JL. Malformations in infants of diabetic mothers. Teratology 1982;25:385e94.
30. McElduff A, Cheung NW, McIntyre HD, et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005;183:373e7.
31. Confidential Enquiry into Maternal and Child Health. Diabetes in Pregnancy: are we providing the best care? Findings of a National Enquiry: England, Wales and Northern Ireland. London: CEMACH, 2007.
32. Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417e22.
33. Hirsch IB. Insulin analogues. N Engl J Med 2005;352:174e83.
34. Kurtzhals P, Schäffer L, Sørensen A, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999e1005.
35. Hawthorne G. Metformin use and diabetic pregnancy-has its time come? Diabet Med 2006;23:223e7.
36. Nicholson W, Bolen S, Witkop CT, et al. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 2009;113:193e205.
37. Briggs GG, Ambrose PJ, Nageotte MP, et al. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005;105:1437e41.
38. Feig DS, Briggs GG, Koren G. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift? Ann Pharmacother 2007;41:1174e80.
39. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443e51.
40. Saji H, Yamanaka M, Hagiwara A, et al. Losartan and fetal toxic effects. Lancet 2001;357:363.
41. Gersak K, Cvijic M, Cerar L. Angiotensin II receptor blockers in pregnancy: a report of five cases. Reprod Toxicol 2009;28:109e12.
42. Briggs GG, Freeman RA, Yaffe S. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. In: Wilkins WA, ed. British National Formulary. 7th edn. Philadelphia: Lippincott, Williams and Wilkins, 2007.
43. Joint Formulary Committee. British National Formulary. Vol. 53. London: British Medical Association and Royal Pharmaeutical Society of Great Britain, 2007.
44. Edison RJ, Muenke M. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004;350:1579e82.
45. Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 women with diabetes with microalbuminuria. Diabetes Care 2001;24:1739e44.
46. Barboza JM, Dajani NK, Glenn LG, et al. Prenatal diagnosis of congenital cardiac anomalies: a practical approach using two basic views. Radiographics 2002;22:1125e37; discussion 1137e8.
47. Buchanan TA, Kjos SL, Montoro MN, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17:275e83.
48. Raychaudhuri K, Maresh. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol 2000;95:190e4.
49. Mukhopadhyay A, Farrell T, Fraser RB, et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant women with diabetes: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007;197:447e56.
50. Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007;(3):CD005542.
51. Manderson JG, Patterson CC, Hadden DR, et al. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. Am J Obstet Gynecol 2003;189:507e12.
52. de Veciana M, Major CA, Morgan MA, et al. Postprandial verses preprandial glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237e41.
53. Murphy HR, Rayman G, Duffield K, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 2007;30:2785e91.
54. Yogev Y, Chen R, Ben-Haroush A, et al. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol 2003;101:633e8.
55. Kerssen A, de Valk HW, Visser GH. Forty-eight-hour first-trimester glucose profiles in women with type 1 diabetes mellitus: a report of three cases of congenital malformation. Prenat Diag 2006;26:123e7.
56. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008;31:9e14.
57. Hare JW. Medical management. In: Hare JW, ed. Diabetes Complicating Pregnancy: The Joslin Clinic method New York: Liss AR, 1989:35e51.
58. Langer O, Anyaegbunam A, Brustman L, et al. Pregestational diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol 1988;159:616e21.
59. Jovanovic L, Knopp RH, Brown Z, et al. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care 2001;24:1130e6.
60. Rosenn BM, Miodovnik M, Khoury JC, et al. Counterregulatory hormonal responses to hypoglycemia during pregnancy. Obstet Gynecol 1996;87:568e74.
61. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902e12.
62. Leinonen PJ, Hiilesmaa VK, Kaaja RJ, et al. Maternal mortality in type 1 diabetes. Diabetes Care 2001;24:1501e2.
63. Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care 2000;23:1084e91.
64. Arun CS, Taylor R. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes. Diabetologia 2008;51:1041e5.
65. Rahman W, Rahman FZ, Yassin S, et al. Progression of retinopathy during pregnancy in type 1 diabetes mellitus. Clin Experiment Ophthalmol 2007;35:231e6.
66. Temple RC, Aldridge VA, Sampson MJ, et al. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet Med 2001;18:573e7.
67. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992;166:1214e18.
68. Chan WC, Lim LT, Quinn MJ, et al. Management and outcome of sight-threatening diabetic retinopathy in pregnancy. Eye(Lond) 2004;18:826e32.
69. Kitzmiller JL, Combs CA. Management and outcome of pregnancy complicated by diabetic nephropathy. In: Dornhorst A, Hadden DR, eds. Diabetes and Pregnancy: An International Approach to Diagnosis and Management Chichester: John Wiley & Sons Ltd, 1996:167e206.
70. Nielsen LR, Müller C, Damm P, et al. Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuriaepossible effect of early antihypertensive treatment during pregnancy. Diabet Med 2006;23:426e31.
71. Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 women with diabetes with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009;32:38e44.
72. Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 2005;105:480e4.
73. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer-2003e2005. The seventh report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007. Available at http://www. cemach.org.uk/Publications/CEMACH-Publications/Maternal-and-Perinatal-Health. aspx.
74. Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics 2003;111:1152e8.
75. Rajasingam D, Seed PT, Briley AL, et al. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am J Obstet Gynecol 2009;200:395. e1e9.
76. Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001;25:1175e82.
77. Jolly MC, Sebire NJ, Harris JP, et al. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol 2003;111:9e14.
78. Catalano PM, Presley L, Minium J, et al. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009;32:1076e80.
79. Conway DL. Obstetric management in gestational diabetes. Diabetes Care 2007;30(Suppl 2):S175e9.
80. Matsushita E, Matsuda Y, Makino Y, et al. Risk factors associated with preterm delivery in women with pregestational diabetes. J Obstet Gynaecol Res 2008;34:851e7.
81. Lepercq J, Coste J, Theau A, et al. Factors associated with preterm delivery in women with type 1 diabetes: a cohort study. Diabetes Care 2004;27:2824e8.
82. Nohr EA, Bech BH, Vaeth M, et al. Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2007;21:5e14.
83. Mathiesen ER, Christensen AB, Hellmuth E, et al. Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm [correction of analgoritm]. Acta Obstet Gynecol Scand 2002;81:835e9.
84. Kaushal K, Gibson JM, Railton A, et al. A protocol for improved glycemic control following corticosteroid therapy in diabetic pregnancies. Diabet Med 2003;20:73e5.
85. Feldberg D, Dicker D, Samuel N, et al. Intrapartum management of insulindependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP). Acta Obstet Gynecol Scand 1988;67:333e8.
86. Taylor R, Lee C, Kyne-Grzebalski D, et al. Clinical outcomes of pregnancy in women with type 1 diabetes(1). Obstet Gynecol 2002;99:537e41.
87. Carron Brown S, Kyne-Grzebalski D, Mwangi B, et al. Effect of management policy upon 120 Type 1 diabetic pregnancies: policy decisions in practice. Diabet Med 1999;16:573e8.
88. Barrett HL, Morris J, McElduff A. Watchful waiting: a management protocol for maternal glycaemia in the peripartum period. Aust N Z J Obstet Gynaecol 2009;49:162e7.
89. Grummer-Strawn LM, Mei Z. Does breastfeeding protect against pediatric overweight? Analysis of longitudinal data from the Centers for Disease Control and Prevention Pediatric Nutrition Surveillance System. Pediatrics 2004;113:e81e6.
90. Gillman MW, Rifas-Shiman SL, Berkey CS, et al. Breast-feeding and overweight in adolescence: within-family analysis [corrected]. Epidemiology 2006;17:112e14.
91. Mayer-Davis EJ, Rifas-Shiman SL, Zhou L, et al. Breast-feeding and risk for childhood obesity: does maternal diabetes or obesity status matter? Diabetes Care 2006;29:2231e7.
92. Mayer-Davis EJ, Dabelea D, Lamichhane AP, et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCh for diabetes in youth case-control study. Diabetes Care 2008;31:470e5.
93. Metzger BE, Lowe LP, et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991e2002.
94. Metzger BE, Gabbe SG, et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676e82.
95. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003e15.
96. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134e8.
97. Lauenborg J, Grarup N, Damm P, et al. Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 2009;94:145e50.
98. Catalano PM, Huston L, Amini SB, et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903e16.
99. Lauenborg J, Hansen T, Jensen DM, et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 2004;27:1194e9.
100. Dornhorst A, Bailey PC, Anyaoku V, et al. Abnormalities of glucose tolerance following gestational diabetes. Q J Med 1990;77:1219e28.
101. Damm P, Kühl C, Buschard K, et al. Prevalence and predictive value of islet cell antibodies in women with gestational diabetes. Diabet Med 1994;11:558e63.
102. Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93:4774e9.
103. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773e9.
104. Martin AO, Simpson JL, Ober C, et al. Frequency of diabetes mellitus in mothers of probands with gestational diabetes: Possible maternal influence on the predisposition to gestational diabetes. Am J Obstet Gynecol 1985;151:471e5.
105. Beischer NA, Oats JN, Henry OA, et al. Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes 1991;40(Suppl 2):35e8.
106. Henry OA, Beischer NA. Long-term implications of gestational diabetes for the mother. Baillieres Clin Obstet Gynaecol 1991;5:461e83.
107. Dornhorst A, Paterson CM, Nicholls JS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9:820e5.
108. Benjamin E, Winters D, Mayfield J, et al. Diabetes in pregnancy in Zuni Indian women. Prevalence and subsequent development of clinical diabetes after gestational diabetes. Diabetes Care 1993;16:1231e5.
109. Metzger BE, Cho NH, Roston SM, et al. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993;16:1598e605.
110. Löbner K, Knopff A, Baumgarten A, et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006;55:792e7.
111. Lee AJ, Hiscock RJ, Wein P, et al. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007;30:878e83.
112. Peters RK, Kjos SL, Xiang A, et al. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996;347:227e30.
113. Buchanan TA, Xiang AH, Peters RK, et al. Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes 2000;49:782e8.
114. Otani H, Tanaka O, Tatewaki R, et al. Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 1991;40:1245e50.
115. Eriksson UJ, Borg LA. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in culture rat embryos. Diabetes 1993;42:411e19.
116. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002;51:2796e803.
117. Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 2007;30:1314e19.
118. Zielinsky P. Role of prenatal echocardiography in the study of hypertrophic cardiomyopathy in the fetus. Echocardiography 1991;8:661e8.
119. Mimouni F, Tsang RC, Hertzberg VS, et al. Polycythemia, hypomagnesemia, and hypocalcemia in infants of mother with diabetes. Am J Dis Child 1986;140:798e800.
120. Widness JA, Susa JB, Garcia JF, et al. Increased erythropoiesis and elevated erythropoietin in infants born to mother with diabetes in hyperinsulinemic rhesus fetuses. J Clin Invest 1981;67:637e42.
121. Salvesen DR, Brudenell JM, Snijders RJ, et al. Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1993;168:88e94.
122. Williams AF. Hypoglycaemia of the newborn: a review. Bull World Health Organ 1997;75:261e90.
123. Hawdon JM. Hypoglycemia in newborn infants: defining the features associated with adverse outcomesda challenging remit. Commentary to Rozance PJ and Hay WW: hypoglycemia in newborn infants: Features associated with adverse outcomes (Biol Neonate 2006;90:74e86). Biol Neonate 2006;90:87e8.
124. Fraser RB, Bruce C. Amniotic fluid insulin levels identify the fetus at risk of neonatal hypoglycemia. Diabet Med 1999;16:568e72.
125. Hawdon JM, Ward Platt MP, Aynsley-Green A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch Dis Child 1992;67(4 Spec No):357e65.
126. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycemia. BMJ 1988;297:1304e8.
127. Beard AG, Panos TC, Marasigan BV, et al. Perinatal stress and the premature neonate. II. Effect of fluid and calorie deprivation on blood glucose. J Pediatr 1966;68:329e43.
128. Hawa MI, Beyan H, Buckley LR, et al. Impact of genetic and non-genetic factors in type 1 diabetes. Am J Med Genet 2002;115:8e17.
129. Ridderstrale M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol 2009;297:10e17.
130. Weiss PA, Scholz HS, Haas J, et al. Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 2001;184:470e5.
131. Sobngwi E, Boudou P, Mauvais-Jarvis F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003;361:1861e5.
132. Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008;31:340e6.
133. Pettitt DJ, Aleck KA, Baird HR, et al. Congenital susceptibility to NIDDM: Role of intrauterine environment. Diabetes 1988;37:622e8.
134. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000;49:2208e11.
135. Alcolado JC, Laji K, Gill-Randall R. Maternal transmission of diabetes. Diabet Med 2002;19:89e98.
136. Ramachandran A, Snehalatha C, Satyavani K, et al. Type 2 diabetes in Asian-Indian urban children. Diabetes Care 2003;26:1022e5.
137. Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. J Matern Fetal Med 2000;9:83e8.
138. Gautier JF, Wilson C, Weyer C, et al. Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes 2001;50:1828e33.